Visit our main locations

Canada / Denmark / Hungary
 Events
Seminar: How to Screen for Arrhythmias in Safety Pharmacology...
 

SOT 2010, Booth # 601
 

Fact Sheet 

 

Q3 2009 Highlights

    • Revenue of $13.1 million
    • Net loss of $1.7 million
    • Net loss per share of $0.09
    • Backlog of $28.1 million 
    • Active backlog of $11.5 million 

 

Investor Information

  • TSX Symbol: LRI
  • Shares Outstanding: 52.7M
  • Fully Diluted: 58.2M
  • Market Cap. Nov. 16, 09: $25.3 M.
  • Year-end: December 31st

Ownership

  • Management: 1%
  • Institutions: ≈ 75%
  • Retail: ≈ 24%

 

Management Team

  • Luc Mainville, President and CEO
  • Louise Bussières, Vice-President, Finance
  • Andy Makin, Managing Director, Denmark
  • Christopher Banks, Managing Director, Hungary
  • Denis Pilon, Chief Operating Officer, Canada

2009 Highlights

  • $39.9million revenue
  • $4.3 million net loss
  • $0.24 loss per share
1-888-353-2240    
Document center   
Inquiry form   
Client center   
     
Français | Home | About | Investor Relations | Careers | Corporate Profile | Products | Animal Welfare | Events | Customers Services
Copyright © 2006 LAB Research Inc. All Rights Reserved | Data Privacy Policy